Posts Tagged ‘Pharmaceuticals’
June 5th by Max Chen
After a sharp sell-off in March and languish trading through May, the biotechnology sector and...
January 21st by Todd Shriber
It is not hyperbole to say 2013 was the year of the health care exchange trade fund. Multiple...
November 20th by Max Chen
The health care industry, along with related exchange traded funds, was salivating at the untapped...
November 16th by Tom Lydon
Congress is working on reform legislation in the pharmaceutical industry to stomp out copycat drug...
October 11th by Todd Shriber
Biotechnology ETFs, a leadership group for all of this year, succumbed to selling pressure this...
September 5th by Tom Lydon